Immucor CEO to step down; PerkinElmer buys U.K.'s Dexela;

> Immucor has announced that Dr. Gioacchino De Chirico will step down as president and CEO and as a director of the company. Joshua Levine has been appointed president, CEO and director. Prior to his retirement in June 2012, De Chirico will remain with the organization to ensure a smooth transition. Immucor release

> PerkinElmer has acquired Dexela Limited, a London-based provider of flat panel complementary metal-oxide-semiconductor X-ray detection technologies and services. PerkinElmer release

> Inspire Medical Systems has announced The STAR trial, evaluating both the safety and effectiveness of Inspire upper airway stimulation therapy, is currently under way at nine leading medical centers across the U.S. and at four sites in Europe. Inspire Medical release

> A unit of Enzo Biochem has reached an agreement with IncellDx of Menlo Park, CA, for the rights to market a proprietary laboratory test that is based upon HPV OncoTect, an advanced molecular diagnostic technology for quantifying specific biomarkers associated with an increased risk of progression to cervical cancer. Upon receiving the appropriate approvals, Enzo will become the first New York licensed reference laboratory to offer the test. Enzo release

> Thoratec EVP and CFO David Smith has resigned from his position to pursue other business opportunities. Smith will remain with Thoratec through July 1 and assist in the transition process. Thoratec release

> EarlySense, which is currently bringing to market the most advanced, contact-free, patient monitoring solution for hospitals and nursing homes, announced it has received FDA clearance and CE approval for the new wireless (WiFi) communications component of its solution. The WiFi system wirelessly connects the bedside unit of the solution to the Central Display System at the nurses' station. EarlySense release

And Finally... A Dundalk company has developed a medical device that has the potential to help patients who suffer brain injuries or strokes. Eurolec Instrumentation has applied for patents for its new "brain cooling" device which aims to lower the temperature of the brain and help prevent damage from strokes or injuries. News

Suggested Articles

Boehringer Ingelheim tapped Healx to help identify new drug indications and leverage its AI to explore R&D options in neurological diseases.

CMR Surgical will have a new CEO at the top of the year, as it kicks off the global launch of its modular Versius system while awaiting FDA approval.

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.